Lipid changes during the menopause transition in relation to age and weight

American Journal of Epidemiology

Volumn 169, Issue 11, 2009, Pages 1352-1361

  Derby, Carol A ^a   Crawford, Sybil L ^b   Pasternak, Richard C ^c   Sowers, Maryfran ^d   Sternfeld, Barbara ^e   Matthews, Karen A ^f  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Body weight; Lipids; Menopause

Indexed keywords

CHOLESTEROL; ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE DETERMINATION; BODY MASS; DEVELOPMENTAL BIOLOGY; HEALTH SURVEY; HORMONE; LIPID; PROTEIN; WOMENS HEALTH;

AGING; ARTICLE; BODY WEIGHT; CLIMACTERIUM; FEMALE; FOLLOW UP; HUMAN; MENOPAUSE; MENSTRUATION; NORMAL HUMAN; POSTMENOPAUSE; PREMENOPAUSE;

ADULT; AGE FACTORS; BODY WEIGHT; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LINEAR MODELS; LIPIDS; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGED; PROSPECTIVE STUDIES; UNITED STATES;

EID: 66249134613     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp043     Document Type: Article

References (45)

1. Kannel W, Hjortland MC, McNamara PM, et al. Menopause and risk of cardiovascular disease: the Framingham Study. Ann Intern Med. 1976;85(4):447-452.
2. Davis C, Pajak A, Rywik S, et al. Natural menopause and cardiovascular disease risk factors: the Poland and US Collaborative Study on Cardiovascular Disease Epidemiology. Ann Epidemiol. 1994;4(6):445-448.
3. Lindquist O, Bengtsson C, Lapidus L. Relationships between the menopause and risk factors for ischaemic heart disease. Acta Obstet Gynecol Scand Suppl. 1985; 130:43-47.
4. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas. 1990;12(4):321-331.
5. Akahoshi M, Soda M, Nakashima E, et al. Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index. Circulation. 1996;94(1):61-66.
6. Bonithon-Kopp C, Scarabin PY, Darne B, et al. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol. 1990;19(1):42-48.
7. Campos H, McNamara JR, Wilson PW, et al. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab. 1988;67(1):30-35.
8. Bush T, Cowan L, Heiss G, et al. Ovarian function and lipid/ lipoprotein levels. Results from the Lipid Research Clinics Program [abstract]. Am J Epidemiol. 1984;120(3):489.
9. Matthews KA, Meilahn EN, Kuller LH, et al. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989; 321(10):641-646.
10. Do KA, Green A, Guthrie JR, et al. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. Am J Epidemiol. 2000;151(6):584-593.
11. Dahlen GH, Guyton JR, Attar M, et al. Associations of levels of lipoprotein Lp(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;74(4):758-765.
12. Hoefler G, Harnoncourt F, Paschke E, et al. Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis. 1988;8(4):398-401.
13. Heinrich J, Sandkamp M, Kokott R, et al. Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem. 1991;37(11):1950-1954.
14. Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels: the Framingham Offspring Study. Circulation. 1993;87(4): 1135-1141.
15. Sowers M, Crawford SL, Cauley JA, et al. Association of lipoprotein(a), insulin resistance, and reproductive hormones in a multiethnic cohort of pre- and perimenopausal women (the SWAN Study). Am J Cardiol. 2003;92(5):533-537.
16. Matthews KA, Wing RR, Kuller LH, et al. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. A rch Intern Med. 1994;154(20): 2349-2355.
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
18. Randolph JF Jr, Sowers M, Bondarenko IV, et al. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab. 2004;89(4):1555-1561.
19. Heiss G, Johnson NJ, Reiland S, et al. The epidemiology of plasma high-density lipoprotein cholesterol levels: the Lipid Research Clinics Program prevalence study summary. Circulation. 1980;62(suppl IV):IV116-IV136.
20. Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol. 2001;153(9):865-874.
21. Sternfeld B, Wang H, Quesenberry CP Jr, et al. Physical activity and changes in weight and waist circumference in mid-life women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol. 2004;160(9):912-922.
22. Sowers MF, Crawford S, Sternfeld B, et al. SWAN: a multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey J, Marcus R, eds. Menopause: Biology and Pathobiology. New York, NY: Academic Press; 2000.
23. Brambilla DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol. 1994;140(12):1091-1095.
24. Dudley EC, Hopper JL, Taffe J, et al. Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric. 1998;1(1):18-25.
25. Research on the menopause in the 1990s. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser. 1996;866: 1-107.
26. Burger HG, Dudley EC, Hopper JL, et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab. 1999;84(11):4025-4030.
27. Burger HG. Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition - an analysis of FSH, oestradiol and inhibin. Eur J Endocrinol. 1994;130(1):38-42.
28. Cooper GS, Baird DD. The use of questionnaire data to classify peri- and premenopausal status. Epidemiology. 1995;6(6): 625-628.
29. Steiner P, Freidel J, Bremner W, et al. Standardization of micromethods for plasma cholesterol, triglyceride and HDL-cholesterol with the Lipid Clinics' methodology [abstract]. J Clin Chem Clin Biochem. 1981;19(8):850.
30. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J Lipid Res. 1978;19(1): 65-76.
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
32. Myers GL, Cooper GR, Winn CL, et al. The Centers for Disease Control-National Heart, Lung, and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clin Lab Med. 1989;9(1):105-135.
33. Huang MH, Schocken M, Block G, et al. Variation in nutrient intakes by ethnicity: results from the Study of Women's Health Across the Nation (SWAN). Menopause. 2002;9(1): 309-319.
34. Sternfeld B, Ainsworth BA, Quesenberry CP. Physical activity patterns in a diverse population of women. Prev Med. 1999; 28(3):313-323.
35. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936-942.
36. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford, United Kingdom: Clarendon Press, Publishers; 1994.
37. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Contr. 1974;19(6):716-723.
38. Efron B. The Jackknife, the Bootstrap, and Other Resampling Plans. Philadelphia, PA: SIAM, Publishers; 1982.
39. SAS Institute, Inc. SAS OnlineDoc®, Version 9.1. Cary, NC: SAS Institute, Inc, Publishers; 1999.
40. Fukami K, Koike K, Hirota K, et al. Perimenopausal changes in serum lipids and lipoproteins: a 7-year longitudinal study. Maturitas. 1995;22(3):193-197.
41. Hall G, Collins A, Csemiczky G, et al. Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women. Maturitas. 2002;41(3):177-185.
42. Sowers MR, Jannausch M, McConnell D, et al. Hormone predictors of bone mineral density changes during the menopause transition. J Clin Endocrinol Metab. 2006;91(4): 1261-1267.
43. Sowers MR, Greendale GA, Bondarenko I, et al. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int. 2003;14(3): 191-197.
44. Randolph JF Jr, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab. 2005;90(11):6106-6112.
45. Matthews KA, Sowers MF, Derby CA, et al. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J. 2005;149(6): 1066-1073.